Executive summary
The proposition — “The ultimate capital is physical capital: your body; monetary capital is a means to build it” — contains an important truth, but it becomes much more rigorous after two corrections.
First, in standard economics, physical capital means produced nonhuman assets such as equipment, structures, and intellectual-property products, not the human body. The body is better described as health capital, following Michael Grossman, or as the health component of human capital. The OECD defines human capital broadly as characteristics embodied in people that contribute to productivity, while the World Bank explicitly includes health alongside knowledge and skills. citeturn17search0turn17search1turn17search6turn18search3
Second, money is not health. It is a highly convertible resource that can purchase some of the inputs into health: nutritious food, medical care, safer housing, exercise opportunities, education, time, convenience, recovery, and insulation from financial stress. Yet the conversion is neither automatic nor linear. Randomized evidence from Sweden is especially instructive: large lottery wealth shocks had essentially no detectable effect on adult mortality or most health-care utilization over the following decade, despite strong observational wealth–mortality gradients. citeturn20view0turn20view1 By contrast, cash transfers in poor Kenyan households improved food security and psychological well-being, and a large 2025 randomized-study working paper reports large reductions in infant and under-five mortality. citeturn15search2turn15search19turn13search31 The marginal health value of money is therefore highly dependent on what constraints money removes.
The U.S. observational gradient is nevertheless enormous. Chetty and colleagues, linking tax records with mortality records, found a life-expectancy gap at age 40 between the highest and lowest income percentiles of about 14.6 years for men and 10.1 years for women. But that gradient cannot simply be interpreted as the causal return to giving someone more cash: health affects income, and education, occupation, behaviors, place, family conditions, and other factors affect both. citeturn15search0turn15search4 The Swedish lottery experiment makes this distinction between association and causal convertibility particularly clear. citeturn20view0
The proposition fares differently under different philosophical frameworks. Stoicism largely rejects the word “ultimate”: health and wealth are preferred but ultimately external “indifferents,” whereas virtue is the genuine good. citeturn17search3turn17search23 Utilitarianism treats bodily investment as justified to the extent that it produces more well-being and reduces suffering than alternative uses of resources; this immediately introduces opportunity cost. citeturn18search25 Sen’s capability approach provides the strongest philosophical formulation of the thesis: money is a means, while what ultimately matters is the substantive freedom to be and do things one has reason to value. Bodily health is therefore both intrinsically valuable and an enabling condition for many other capabilities. citeturn18search16turn18search28
Economically, Grossman’s health-capital model is almost exactly the formal version of the intuition. Health is a durable stock producing healthy time; it depreciates and can be maintained or augmented using medical care, time, information, and other inputs. citeturn18search3turn18search15 Becker’s human-capital framework similarly treats expenditures on education and training as investments whose present costs can generate future returns. citeturn19search0turn19search6 The crucial addition is that health yields not merely earnings but also direct consumption value: being able to move, think, sleep, experience, care for others, and live without avoidable suffering.
The strongest practical conclusion is consequently not “spend as much as possible on the body.” It is:
Use monetary capital to remove the highest-return constraints on health and functional capacity, while preserving enough financial capital to protect those gains over time.
For a smoker, cessation treatment is likely to dominate a premium gym, wearable, or supplement. Counseling plus medication can more than double the chances of quitting. citeturn16search3turn16search17 For someone with prediabetes, a structured lifestyle program has unusually strong causal evidence: the Diabetes Prevention Program reduced incident diabetes by 58%, versus 31% with metformin, compared with placebo. citeturn14search0 For an eligible person with high cardiovascular risk and hypertension, evidence-based blood-pressure treatment can reduce cardiovascular events and mortality, though intensive treatment also creates adverse-event risks. citeturn14search1turn14search20 For a healthy person whose principal barrier is inactivity, much of the highest-value intervention may cost almost nothing: current U.S. guidance recommends 150–300 minutes of moderate aerobic activity weekly plus muscle strengthening on at least two days. citeturn16search6turn16search13
At higher incomes, the most rational use of additional money increasingly shifts from purchasing more “health products” to purchasing time, adherence, environment, expertise, and optionality. Meanwhile returns to luxury wellness technology can be low: in the IDEA randomized trial, adding wearable technology to an otherwise standardized behavioral weight-loss intervention did not improve weight loss and actually produced less weight loss at 24 months. citeturn4search27
Thus, the body is best understood not as the sole or “ultimate” capital, but as foundational capability capital: a partially depreciating, partly nonreplaceable asset without which financial, intellectual, and social capital become progressively harder to use. Money is valuable partly because it can protect that foundation. But money, relationships, knowledge, institutions, purpose, and health are better understood as complementary assets in a portfolio of human flourishing, not as a hierarchy in which one can simply replace all the others.
Concepts and philosophical framing
What “capital” means here
A rigorous treatment requires separating three concepts.
| Concept | Standard meaning | Relevance to the proposition | Important qualification |
|---|---|---|---|
| Physical capital | In conventional national accounting, produced assets repeatedly used in production, including equipment, structures, and intellectual-property products. citeturn17search2turn17search6 | The body can metaphorically be described as “physical capital.” | Economically this is nonstandard terminology; a human body is not classified as physical capital. |
| Human capital | Knowledge, skills, competencies, health, and other embodied attributes that contribute to productive capacity. OECD’s narrower definition emphasizes knowledge, skills and personal characteristics; the World Bank explicitly includes health. citeturn17search0turn17search1 | Contains the economically productive dimension of bodily and cognitive capacity. | Treating humans only as productive assets risks reducing their intrinsic worth to output. |
| Health capital | In Grossman’s model, a durable stock of health that produces healthy time and can be affected by investment. citeturn18search3turn18search15 | The technically strongest concept for the user’s “body as capital” idea. | Unlike a machine, the body has consciousness, welfare, rights, path dependence, biological limits, and intrinsic value. |
| Monetary/financial capital | “Monetary capital” has no single standard household-economic definition. Operationally here it means liquid or readily deployable financial resources. OECD household financial assets include deposits, currency, securities, equity and other financial claims. citeturn18search2turn18search30 | Provides purchasing power that can be transformed into health inputs or saved as future health-security capacity. | Money affects health through conversion mechanisms rather than directly. |
| Bodily capital | A useful analytical term for this report rather than a standardized national-accounting category. | The stock of strength, cardiovascular capacity, mobility, metabolic health, sensory and neurological function, recovery capacity, and controlled disease that permits action. | Some dimensions cannot be purchased, and many cannot be fully restored once lost. |
This terminology changes the proposition from:
Money should be transformed into physical capital because the body is the ultimate asset.
to the more defensible:
Financial resources can be transformed, with context-dependent and diminishing marginal returns, into health capital; health capital is foundational because it expands healthy time, agency, productive capacity, and the feasible set of lives a person can lead.
That formulation also avoids equating a person with his or her economic productivity. The World Bank’s own modern human-capital definition includes health as an accumulated capability, while Grossman’s theory distinguishes health itself from medical care, which is merely one input into producing it. citeturn17search1turn18search15
Stoicism: the body matters, but it is not ultimate
Stoicism provides perhaps the sharpest philosophical objection. Mainstream Stoic ethics regards health, wealth, and reputation as preferred indifferents: ordinarily worth choosing, but not what makes a life morally good. Virtue occupies that role. citeturn17search3turn17search27
The practical implication is subtle. A Stoic need not neglect the body. It is perfectly compatible with Stoicism to exercise, obtain medical care, maintain strength, and use wealth prudently to preserve health. But doing so is an exercise of good judgment rather than the final purpose of existence. Health remains partly vulnerable to disease, accident, aging, and circumstances outside one’s control. citeturn17search23
Translated into investment language, Stoicism says:
Optimize stewardship, not control. Invest rationally in the body, but do not make bodily perfection a prerequisite for flourishing or self-worth.
This is an important corrective to modern “longevity optimization” culture. A portfolio in which every dollar and hour is subordinated to extending biological life can itself become inconsistent with a good life if it crowds out friendship, duty, courage, meaningful work, or equanimity.
Utilitarianism: health is valuable through consequences
Millian utilitarianism assesses choices and institutions by their consequences for human happiness and suffering. citeturn18search25 On this view, there is no reason a priori that the body must dominate all other investments.
A dollar spent preventing a disabling disease can produce very high utility. A dollar spent on an expensive device with negligible health effect may produce less utility than money spent on housing security, education, relationships, leisure, charitable aid, or financial resilience. The correct comparison is therefore marginal welfare per unit of scarce resource, including the individual’s time.
This logic has an especially important social implication: the utilitarian case for a health dollar generally becomes stronger where the marginal benefit is larger. If $1,000 removes food insecurity or enables treatment of an untreated disease, its welfare consequences may dwarf the same $1,000 used for a marginal optimization by an already affluent, healthy person. The large contrast between cash-transfer evidence in poor Kenyan households and lottery-wealth evidence in Sweden is consistent with — although it does not by itself prove — this diminishing-constraint interpretation. citeturn15search19turn20view2
Capability approach: money as means, bodily functioning as freedom
Amartya Sen’s capability approach is the closest philosophical match to the strongest version of the thesis. Capabilities are substantive freedoms to achieve valuable “beings and doings.” citeturn18search28 Sen’s Development as Freedom places freedom rather than income alone at the center of development evaluation. citeturn18search16
This matters because two people with the same monetary resources may have radically different ability to convert them into functioning. Disability, chronic disease, caregiving obligations, geography, discrimination, local prices, health-care systems, knowledge, and biological differences alter the conversion rate from resources to capabilities.
From this perspective:
money → conversion factors → bodily functioning → substantive freedom
is a better chain than:
money → body → money.
Health matters not merely because it raises earnings. Being able to walk, see, communicate, sleep, think clearly, care for family, participate politically, work voluntarily, travel, or simply experience life without preventable pain has value independent of market productivity. That is why “health capital” should not be valued solely at the income it generates.
Economic model of bodily investment
Grossman’s classic 1972 model supplies the core economics. He conceptualized health as a durable capital stock producing healthy time. Medical care is not health itself; it is one among several inputs that can create or maintain health. citeturn18search3turn18search15 This complements Becker’s human-capital framework, in which education and training are investments involving current costs in exchange for possible future benefits. citeturn19search0turn19search1
A useful stylized extension is:
[
H_{t+1}=(1-\delta_t)H_t+
I(M_t,T_t,K_t,E_t,Z_t)
]
where:
- (H_t) is bodily or health capital;
- (\delta_t) is biological depreciation, disease burden, injury, or other deterioration;
- (M_t) is monetary expenditure;
- (T_t) is personal time devoted to sleep, exercise, cooking, treatment, recovery, and care;
- (K_t) is relevant knowledge and behavioral skill;
- (E_t) is physical and social environment;
- (Z_t) is available medical and other technology.
This is a synthesis rather than Grossman’s exact equation, but it makes an essential point from the model explicit: money is only one input. Grossman’s framework itself emphasizes that the “shadow price” of health depends on much more than the price of medical care. citeturn18search15
Money’s special role: convertibility
Money does possess one unusual property: optionality. Unlike a treadmill, medication, or medical procedure, financial assets have not yet committed their owner to a particular production process. OECD financial-balance-sheet definitions illustrate this general feature of financial wealth as claims such as deposits, securities, and equity that preserve financial value and purchasing capacity. citeturn18search2turn18search22
Financial capital can potentially become:
[
$ \rightarrow
\begin{cases}
\text{food}\
\text{medicine}\
\text{housing}\
\text{exercise access}\
\text{education}\
\text{childcare}\
\text{transport}\
\text{reduced work hours}\
\text{professional expertise}\
\text{future insurance against shocks}
\end{cases}
\rightarrow H
]
Its advantage is therefore less that “money is health” than that money preserves choices among future health-production technologies.
The conversion system can be visualized as follows:
flowchart LR
M["Monetary resources"] --> A["Access and affordability"]
M --> T["Time bought back"]
M --> F["Financial security"]
M --> E["Education / expertise"]
M --> N["Safer environment"]
A --> NU["Nutrition"]
A --> HC["Health care and medicines"]
A --> EX["Exercise / rehabilitation"]
T --> EX
T --> SL["Sleep and recovery"]
T --> CE["Caregiving / meal preparation"]
F --> ST["Lower financial strain"]
E --> AD["Better decisions and adherence"]
N --> HX["Lower hazard exposure"]
NU --> B["Biological risk factors"]
HC --> B
EX --> B
SL --> B
ST --> B
HX --> B
AD --> B
B --> H["Health and functional capacity"]
H --> Q["Healthy time / capabilities / well-being"]
H --> P["Productivity and earning capacity"]
P --> M
The feedback arrow from health to monetary resources is economically important. Health can affect labor supply and productivity, meaning that observational correlations between money and health suffer from reverse causality as well as confounding. That is one reason randomized and quasi-random wealth evidence deserves more weight than simple income–health correlations. The Swedish lottery study was explicitly designed to identify the causal effect of wealth shocks against this background. citeturn20view2
Opportunity cost and the marginal-dollar rule
An economically rational investor should not maximize (H) regardless of cost. A more general objective is something like:
[
\max ; W(H,C,L,R,\ldots)
]
subject to constraints on money and time, where (C) represents other consumption, (L) relationships/leisure and other life activities, and (R) financial resilience.
The relevant question is therefore not:
“Could another $1,000 improve my body?”
but:
“Is this the best risk-adjusted use of the next $1,000 and the time that accompanies it?”
Three principles follow.
Binding constraints produce large returns. Treating nicotine dependence, uncontrolled hypertension, serious food insecurity, or lack of access to necessary medication can plausibly dominate small optimizations of an otherwise healthy lifestyle. The DPP, SPRINT, and smoking-cessation evidence demonstrate how large effects can emerge when an intervention targets a meaningful baseline risk. citeturn14search0turn14search20turn16search3
Inputs are complementary. Money spent on a gym accomplishes little without time and adherence. A wearable is of limited value unless information changes behavior. Medicines require diagnosis, access, and appropriate use. The IDEA wearable trial, where added technology failed to improve weight loss, is a clean illustration of why purchasing an input is not the same as purchasing the outcome. citeturn4search27
Financial capital and bodily capital are complements, not pure substitutes. Spending down every reserve on marginal health optimization can make future health harder to protect. Conversely, accumulating financial wealth by chronically sacrificing sleep, movement, medical care, or recovery can degrade the biological asset that generates future earning capacity. This complementarity follows directly from the Grossman conception of health as a stock requiring time and other inputs and from the fact that financial resources retain future purchasing power. citeturn18search15turn18search2
What the empirical evidence actually shows
The evidence strongly supports a relationship between economic resources and health, but it does not support a simple law in which more money mechanically generates longer life.
Money and health: association is strong; causality is conditional
| Evidence | Design and population | Main finding | What it establishes | Main limitation |
|---|---|---|---|---|
| Chetty et al., JAMA, 2016 | U.S. tax and mortality records; roughly 1.4 billion person-year observations | At age 40, life-expectancy difference between richest and poorest 1% was about 14.6 years for men and 10.1 for women. citeturn15search0turn15search4 | Very large socioeconomic gradient in longevity. | Observational: does not isolate the causal effect of income. |
| Cesarini et al., QJE, 2016 | Swedish lotteries; quasi-random substantial wealth shocks linked to administrative health records | Lottery wealth had no detectable effect on adult mortality or overall health-care utilization; estimates could rule out most of the observational mortality gradient as causal in this setting. citeturn20view0turn20view1 | Strong evidence that merely becoming richer need not substantially improve adult health. | Sweden had universal publicly financed health care; authors explicitly caution against extrapolating to poorer or different health-system settings. citeturn20view1 |
| Haushofer & Shapiro, QJE, 2016 | Randomized unconditional cash transfers to poor rural Kenyan households | Increased consumption, assets, food security and psychological well-being; no overall cortisol effect. citeturn15search2turn15search19 | Cash can improve important determinants of health and subjective welfare when material constraints bind. | Short-run and context-specific; not a longevity trial. |
| Large Kenya cash-transfer mortality study, 2025 | Cluster-randomized cash-transfer program covering hundreds of villages; working paper | Authors report approximately 48% fewer infant deaths and 45% fewer under-five deaths after accounting for spillovers. citeturn13search31 | Suggests potentially very large survival returns to cash under severe resource constraints. | As of the cited version, an NBER working paper rather than a final journal article; child-survival effects in rural Kenya should not be generalized mechanically to affluent adults. |
| Moving to Opportunity | U.S. randomized housing-voucher experiment among low-income families | Moving to lower-poverty neighborhoods produced significant improvements in directly measured adult obesity/diabetes outcomes; treatment-on-treated estimates imply roughly 40% lower extreme obesity and about half the diabetes prevalence among movers. citeturn15search3turn15search28 | Environment itself can be a causal health input. | Only about half of the relevant voucher group used the voucher; mover effects differ from simple offer effects. citeturn15search28 |
| Oregon Health Insurance Experiment | Medicaid access randomized through a lottery | Medicaid increased health-care use, improved depression-related and financial outcomes, and improved diabetes detection/management, but did not significantly improve several measured physical-health biomarkers over two years. citeturn14search2 | Insurance buys access and financial protection, but health-stock changes need not appear rapidly in biomarkers. | Two-year horizon; findings do not mean insurance has no longer-run health value. |
Taken together, these studies imply a constraint model of money and health.
At low resource levels, money can directly relax constraints on nutrition, shelter, medical access and safety; causal health returns may therefore be large. citeturn15search19turn13search31
At higher resource levels, where basic health services and material needs are already available, additional unrestricted wealth may have much smaller physical-health returns. The Swedish lottery experiment found its adult health effects tightly concentrated around zero despite very large positive wealth shocks. citeturn20view1turn20view2
This is a stronger explanation than either extreme claim — “money buys health” or “money cannot buy health.”
Targeted spending often matters more than unrestricted spending
The evidence becomes considerably stronger when the monetary resource is converted into a specific, evidence-based intervention aimed at a known risk.
The Diabetes Prevention Program randomized adults at high risk of developing type 2 diabetes. Intensive lifestyle intervention reduced diabetes incidence by 58%, and metformin by 31%, relative to placebo. citeturn14search0 A 10-year economic evaluation found the lifestyle intervention cost-effective and metformin economically attractive relative to placebo, although cost-effectiveness depends on delivery format and perspective. citeturn12search0
SPRINT randomized people at elevated cardiovascular risk to more versus less intensive systolic-blood-pressure control. Intensive treatment reduced the primary cardiovascular outcome and all-cause mortality; the original trial reported an all-cause mortality hazard ratio of 0.73, while also reporting more of some treatment-related adverse events. citeturn14search1turn14search20 Subsequent economic analysis found intensive treatment generally cost-effective in the SPRINT-eligible population. citeturn14search17
For tobacco dependence, CDC guidance reports that counseling and medication are each effective and that combining them can more than double the chance of quitting. citeturn16search3turn16search17 This is a particularly important example because an inexpensive intervention may dominate vastly more expensive “optimization” spending when the baseline risk is high.
SELECT provides a modern example at the other end of the cost spectrum. In people with overweight or obesity, established cardiovascular disease, and no diabetes, semaglutide reduced major adverse cardiovascular outcomes relative to placebo. citeturn14search3 The result establishes clinical efficacy for that defined high-risk population; it does not establish that pharmacologic weight loss is an efficient or appropriate general-purpose longevity purchase for healthy people.
Exercise, diet, sleep and fitness
Physical activity is unusually important because much of it does not require substantial monetary expenditure. Current U.S. guidance calls for 150–300 minutes of moderate aerobic activity weekly, or the vigorous equivalent, plus muscle strengthening on at least two days per week. citeturn16search6turn16search10 Device-measured observational meta-analysis involving more than 36,000 middle-aged and older adults found strong inverse associations between physical activity and mortality, although such evidence remains observational rather than proof that a specific exercise dose causes a precise extension of lifespan. citeturn5search5
Dietary intervention evidence likewise supports the proposition that what money buys matters more than the fact of spending it. The reanalyzed PREDIMED trial found fewer major cardiovascular events in high-risk participants assigned Mediterranean dietary patterns supplemented with extra-virgin olive oil or nuts versus a control diet; importantly, the original report was withdrawn and republished after irregularities in randomization procedures were discovered, so the reanalysis is the appropriate version to cite. citeturn5search2
Sleep illustrates a different issue: time can be the scarce capital. A randomized sleep-extension trial in habitually short-sleeping adults with overweight found that individualized sleep counseling extended sleep and reduced energy intake by roughly 270 kcal/day during the short experimental period. citeturn4search35 This does not establish a longevity effect, but it shows how resources spent on schedules, childcare, commuting, bedroom conditions or work flexibility could act indirectly by making recovery behavior feasible.
Technology can help, but buying data is not buying health
Consumer health technology deserves skepticism proportional to its marketing claims.
The IDEA randomized trial found that adding wearable technology to a standard behavioral weight-loss program produced less, not more, weight loss after 24 months than the standard behavioral intervention alone. citeturn4search27 Conversely, a meta-analysis of wearable activity trackers in people with cardiometabolic conditions found activity benefits, particularly when technology was coupled to health-professional involvement. citeturn4search23
The synthesis is straightforward:
Technology is more valuable when it closes a behavioral feedback loop than when it merely measures the body.
A heart-rate monitor, continuous data stream, smart scale or app is an intermediate good. Its economic value equals the incremental behavioral or clinical improvement it produces, not the richness of the measurements it collects.
A causal-evidence hierarchy
The empirical literature therefore suggests the following hierarchy:
[
\textbf{Money alone}
;<;
\textbf{Money removing a binding constraint}
;<;
\textbf{Money funding a proven, targeted intervention with adherence}
]
This is a conceptual synthesis rather than a universal statistical ranking, but it is consistent with the contrast between the Swedish lottery, cash-transfer, housing, DPP, SPRINT and technology evidence. citeturn20view1turn15search19turn15search28turn14search0turn14search20turn4search27
Conversion mechanisms and practical investment pathways
The practical problem is not “how much should I spend on health?” but which bottleneck should the next dollar remove?
Relative cost categories below are intentionally qualitative because prices, insurance coverage, geography, age, disease status and opportunity costs vary enormously. $ means free or low-cost; $$$$ means potentially major recurring medical or housing expenditure.
Intervention comparison
| Bodily investment | Relative cost | Evidence for meaningful outcomes | Typical horizon | Scalability | Highest-value situation | Principal caveat |
|---|---|---|---|---|---|---|
| Smoking cessation: counseling + evidence-based medication | $–$$ | Very strong, targeted. Combined treatment more than doubles quitting chances. citeturn16search3turn16search17 | Weeks for cessation; years for disease-risk benefits | Very high | Current smoker | Irrelevant to nonsmokers; relapse management matters. |
| Regular aerobic and resistance activity | $ to $$ | Strong health evidence; mortality evidence includes large observational meta-analyses. Federal recommendation: 150–300 min moderate activity + ≥2 strength days. citeturn16search6turn5search5 | Weeks for fitness; months–years for risk reduction | Extremely high | Sedentary/inactive individuals | A gym or device is optional; adherence is the active ingredient. |
| Structured DPP-style lifestyle intervention | $$ | Very strong RCT evidence in prediabetes/high-risk adults: 58% lower diabetes incidence versus placebo. citeturn14search0 | Months–years | High, particularly with group delivery | Prediabetes / high metabolic risk | Cannot extrapolate 58% benefit to low-risk people. |
| Evidence-based management of hypertension / cardiovascular risk | $–$$$ | Very strong in appropriately selected patients. SPRINT showed fewer CV events and deaths with intensive treatment in its eligible population. citeturn14search1turn14search20 | Months–years | High | Diagnosed elevated risk | Targets and medicines require individualized clinical judgment; intensive therapy caused more some adverse events. |
| Higher-quality dietary pattern / food security | $–$$ | Strong for several cardiometabolic outcomes; trial evidence exists for Mediterranean-style patterns in high-risk adults. citeturn5search2 | Weeks for biomarkers; years for events | High | Poor dietary quality, food insecurity, metabolic risk | “Healthy food” spending can become expensive without proportionate benefit; dietary response varies. |
| Sleep opportunity and environment | $–$$$ | Moderate for intermediate outcomes; direct longevity RCT evidence weak. Short sleep-extension RCT reduced energy intake. citeturn4search35 | Days–months | High biologically; structural barriers may limit feasibility | Habitually insufficient sleep | Expensive mattresses/gadgets are not equivalent to sufficient sleep opportunity. |
| Health insurance / access to necessary care | $$–$$$$ | Strong for access and financial protection; short-run physical outcomes can be mixed. Oregon Medicaid experiment reduced financial strain and depression but did not significantly change several biomarkers over two years. citeturn14search2 | Immediate access; years for some health outcomes | System-dependent | Uninsured / underinsured / untreated disease | More utilization is not synonymous with better health; quality and targeting matter. |
| Safer housing / healthier neighborhood / shorter damaging commute | $$$–$$$$ | Causal evidence from MTO that neighborhood conditions can affect obesity and diabetes. citeturn15search3turn15search28 | Years | Low individually; high via policy | Unsafe, stressful, polluted, highly disadvantaged environments | Large financial and social switching costs. |
| Coaching, physical therapy, trainer or supervised exercise | $$–$$$ | Depends strongly on indication; can convert knowledge into adherence and safer execution | Weeks–months | Moderate | Injury, technique, accountability or rehabilitation bottleneck | Quality varies; unnecessary coaching adds cost without changing behavior. |
| Wearables / apps | $–$$ | Mixed. Trackers can increase activity, especially with professional support, but the IDEA trial found no weight-loss advantage from adding wearable technology. citeturn4search23turn4search27 | Days–months | Very high | People who respond to feedback/accountability | Data collection can substitute psychologically for action. |
| Anti-obesity pharmacotherapy when clinically indicated | $$$–$$$$ | Strong in selected groups. SELECT demonstrated cardiovascular benefit from semaglutide in people with overweight/obesity and established CVD without diabetes. citeturn14search3 | Ongoing / years | Constrained by cost, access, supply and medical oversight | Clinically eligible higher-risk patients | Not a generic “longevity drug”; treatment risks, persistence and cost matter. |
| Premium wellness diagnostics, gadgets and optimization services | $$$–$$$$ | Frequently uncertain or product-specific | Variable | Commercially high | Occasionally useful for a defined clinical question | High risk of purchasing information or novelty rather than improved outcomes; compare against established interventions. |
A numerical “cost-effectiveness ranking” across all these categories would create false precision. Smoking cessation, DPP, hypertension treatment, housing relocation and pharmacotherapy have different populations, endpoints, health systems, price years and denominators. DPP lifestyle treatment has been found cost-effective over long follow-up, and economic modeling of SPRINT likewise found intensive treatment economically attractive in the population studied. citeturn12search0turn14search17 But those ratios cannot responsibly be transferred wholesale to an arbitrary individual.
The practical health-capital frontier
A useful conceptual map is:
| Low monetary cost | High monetary cost | |
|---|---|---|
| High expected return when applicable | Walking/aerobic exercise; strength training with simple equipment; smoking cessation; adherence to indicated inexpensive medications; sleep scheduling | Necessary treatment of serious disease; selected pharmacotherapy; rehabilitation; safer housing/location; buying meaningful time autonomy |
| Uncertain or low incremental return | Excessive self-tracking; redundant free apps; low-adherence subscriptions | Prestige wellness clinics; repeated low-value testing; luxury equipment that does not alter behavior; expensive “optimization” purchases with weak outcome evidence |
The correct location of any intervention changes with baseline risk. A blood-pressure medicine can be extraordinarily valuable to one person and inappropriate to another. Semaglutide can have demonstrated cardiovascular benefit in the SELECT population yet be a poor use of resources for somebody outside a clinical indication. citeturn14search3turn14search20
Money can buy time — often an underappreciated health input
For many middle- and high-income individuals, income is no longer the tightest constraint; time and friction are.
Money can potentially substitute for low-value time demands through childcare, a shorter commute, food preparation, domestic help, convenient exercise access, or greater schedule flexibility. The Grossman model explicitly treats personal time as part of health production rather than treating medical spending as sufficient. citeturn18search15
This changes the apparent economics of convenience. Paying more for a gym two minutes away rather than one thirty minutes away can be rational even if the facilities are identical, if proximity materially changes attendance. Paying for pre-prepared nutritious meals may outperform purchasing a sophisticated wearable if meal preparation is the actual bottleneck. The causal claim here is individual and must be tested against behavior; the general principle is that the valuable product is adherence, not the nominal service.
Investment horizons
Health capital is unusual because returns unfold over radically different periods:
timeline
title Typical horizons of bodily investment
Today : Remove acute safety hazards
: Obtain necessary treatment
: Start movement or cessation attempt
Days to weeks : Sleep and energy changes
: Early medication effects
: Exercise skill and routine formation
Months : Cardiorespiratory fitness
: Strength gains
: Weight and metabolic changes where applicable
: Rehabilitation progress
Years : Lower incidence of some chronic diseases
: Compounding effects of sustained activity, diet and risk-factor control
: Neighborhood and environmental effects
Decades : Healthy-time and survival consequences
: Preservation of mobility and independence
: Cumulative interaction between financial and health capital
This creates a behavioral challenge: many bodily investments have immediate costs but delayed benefits, while unhealthy consumption can have immediate rewards and delayed costs. Human-capital theory is fundamentally an intertemporal theory of precisely this kind of choice. Becker analyzed present investment costs against future returns, while Grossman applied the stock-investment logic directly to health. citeturn19search6turn18search3
Tradeoffs, inequality, risks, and major uncertainties
Diminishing returns are central
The proposition becomes misleading when it implies:
[
\text{more money spent on body} \Rightarrow \text{proportionally better body}.
]
The causal evidence rejects such a simple function.
The Swedish lottery study found cross-sectional wealth–mortality gradients but lottery-induced wealth shocks close to zero in their effect on mortality. For 10-year mortality, the researchers could statistically rule out a causal effect even one-sixth as large as the observational gradient. citeturn20view0 They explicitly note that Sweden’s universal health-care system limits generalization. citeturn20view1
Contrast this with poor Kenyan households, where cash improved food security and well-being, and emerging randomized evidence points to major child-survival effects. citeturn15search19turn13search31
A plausible interpretation — explicitly an inference from these different settings — is a concave money-to-health production function:
[
\frac{\partial H}{\partial M} > 0,
\qquad
\frac{\partial^2 H}{\partial M^2}<0
]
over substantial portions of the resource distribution. The first dollars that eliminate hunger, unsafe shelter, untreated disease, nicotine dependence, or lack of transportation can be much more health-productive than the dollars that upgrade an already adequate exercise facility to a luxury one. The cited experiments support context dependence, though they do not identify a universal mathematical curve. citeturn20view2turn15search19
Inequality can compound across forms of capital
The health–income relationship can be self-reinforcing:
[
\text{financial resources}
\rightarrow
\text{better health opportunities}
\rightarrow
\text{more healthy time}
\rightarrow
\text{greater productive capacity}
\rightarrow
\text{financial resources}.
]
The U.S. longevity gradient documented by Chetty et al. is consistent with deep socioeconomic stratification, while geographic variation among low-income Americans suggests that place and local conditions are also important. citeturn15search0 Moving to Opportunity strengthens the causal case that at least some neighborhood conditions can affect health rather than merely correlate with it. citeturn15search3turn15search28
This creates an equity problem if “build your body” is framed purely as personal responsibility. Individuals begin with different genetics, childhood nutrition, wealth, schooling, occupational exposures, neighborhoods, disability burdens and access to care. The capability approach is particularly useful here because it distinguishes equal resources from equal real opportunities to function. citeturn18search28
Health consumerism and moral hazard
The market has an incentive to transform anxiety about aging into demand for products. Yet biological measurement, medical utilization and health are three different things.
The Oregon experiment demonstrates that expanding insurance raises medical use without necessarily producing rapid improvements across measured physical biomarkers. citeturn14search2 The wearable literature similarly shows that giving people more measurements does not guarantee better outcomes. citeturn4search27turn4search23
This is not an argument against medicine, insurance, wearables or diagnostics. It is an argument for evaluating them by the correct endpoint:
[
\text{purchase} \neq \text{health input used effectively} \neq \text{better health}.
]
A rational buyer asks whether the purchase changes behavior, diagnosis, treatment, environmental exposure, or physiological outcomes that matter.
The risk of overcapitalizing the self
The capital metaphor itself has moral costs.
Calling the body an “asset” can sharpen long-term thinking: sleep becomes maintenance, exercise becomes investment, smoking becomes depreciation, and preventive treatment becomes preservation of productive capacity. Grossman’s framework was powerful partly because it formalized those intertemporal choices. citeturn18search3
But the metaphor can become pathological if it makes every meal, workout, biomarker and hour of sleep an optimization problem. Stoicism is useful precisely because it refuses to make health the final measure of a life. citeturn17search3 Sen’s approach likewise evaluates a plurality of capabilities rather than a single maximand such as income or lifespan. citeturn18search28
A perfectly optimized biomarker profile purchased at the cost of meaningful relationships, autonomy, pleasure, vocation or psychological peace would not obviously constitute an optimized life under either framework.
Healthspan is not identical to lifespan
The economically relevant output of bodily investment is not just date of death. Grossman’s original concept emphasizes healthy time, which is closer to functional healthspan than to raw longevity. citeturn18search3 A treatment that improves mobility, pain, cognition or independence without changing mortality can therefore be economically and ethically valuable.
Conversely, a small extension of lifespan with major treatment burden may be less attractive depending on preferences. Cost-effectiveness approaches try to address this with quality-adjusted life-years, but capability theory reminds us that no single metric captures all dimensions of agency and well-being.
Major gaps in the evidence
Several uncertainties prevent a stronger conclusion.
There are very few genuine randomized experiments of adult wealth and decades-long mortality. Randomizing large permanent income differences for decades is ethically and practically difficult. Lottery studies are unusually valuable, but lottery winners are selective populations and institutional settings matter. The Swedish authors themselves emphasize this limitation. citeturn20view1
Income and wealth are not interchangeable. A permanent wage increase, predictable monthly transfer, one-time lottery windfall and accumulated net worth can generate different behavior. The Kenyan cash experiment found differences between monthly and lump-sum transfers, including stronger food-security effects from monthly transfers. citeturn15search19
Many lifestyle studies measure intermediate outcomes rather than lifespan. DPP directly measured diabetes incidence, SPRINT measured cardiovascular events and mortality, but shorter diet, exercise, sleep, wearable and behavioral studies often rely on biomarkers, activity or weight. citeturn14search0turn14search20turn4search35
Generalizability is often narrow. SPRINT applies to its cardiovascular-risk population, DPP to adults at high diabetes risk, and SELECT to people with established cardiovascular disease plus overweight/obesity and no diabetes. Their relative treatment effects should not be assigned to arbitrary healthy populations. citeturn14search0turn14search1turn14search3
Long-term adherence is a major latent variable. An intervention can be highly efficacious under trial conditions yet produce little real-world health capital when inconvenient, unpleasant or unsustainable. The discrepancy between technology ownership and behavioral outcomes is one manifestation of this problem. citeturn4search23turn4search27
Opportunity cost is often incompletely measured. Exercise, medical appointments, food preparation and sleep consume time as well as money. Grossman’s health-production model explicitly treats time as an input, but many consumer comparisons focus only on sticker price. citeturn18search15
Biological depreciation is only partly controllable. Even excellent investment cannot eliminate aging, genetic risk, accidents or disease. This is simultaneously an economic limitation to the capital metaphor and the central Stoic objection to regarding bodily health as the “ultimate” good. citeturn17search23
Actionable recommendations for individuals and policymakers
For individuals: use a hierarchy, not a shopping list
The optimal strategy is best conceived as a health-capital waterfall.
First, eliminate large downside risks and binding constraints. Necessary medication, serious untreated symptoms, tobacco dependence, unsafe living conditions, severe food insecurity, and inability to access clinically indicated care generally deserve attention before marginal wellness optimization. Evidence for tobacco cessation, risk-factor treatment and targeted prevention is substantially stronger than evidence for most consumer wellness products. citeturn16search3turn14search0turn14search20
Second, build the low-cost biological base. Regular aerobic movement and muscle-strengthening activity require surprisingly little capital equipment; current federal guidance remains 150–300 minutes of moderate aerobic activity weekly plus strengthening on at least two days. citeturn16search6turn16search13 Spend money only where it improves the probability of execution: proximity, coaching, appropriate footwear, equipment actually used, childcare or scheduling may be more valuable than premium facilities.
Third, buy adherence and time before buying sophistication. When knowledge is no longer the bottleneck, another book, sensor or dashboard has declining value. Consider whether the marginal dollar can remove friction: a closer facility, rehabilitation, meal preparation, reduced commuting burden, childcare, a clinician or coach, or an environment in which sleep and activity actually happen. Grossman’s model makes time a genuine production input, not an afterthought. citeturn18search15
Fourth, match expenditure to baseline risk. The DPP’s 58% diabetes reduction is compelling for the population it studied, not evidence that everybody should buy an intensive metabolic program. SPRINT and SELECT likewise demonstrate high returns from well-targeted interventions rather than from indiscriminate optimization. citeturn14search0turn14search20turn14search3
Fifth, preserve financial optionality. The objective should not be to convert all financial capital into bodily spending. Financial resources themselves preserve the future ability to absorb medical, employment, housing and caregiving shocks. OECD financial accounts explicitly distinguish stocks of financial assets and liabilities as stores of net financial worth. citeturn18search22 In portfolio terms, health capital and financial capital should be treated as mutually reinforcing buffers.
Finally, demand evidence proportional to price. The more expensive, invasive or recurring an intervention is, the stronger the outcome evidence should be. A useful personal test is:
[
\boxed{
\text{Value}
\approx
\frac{
P(\text{I will actually use it})
\times
\text{expected meaningful health gain}
\times
\text{duration of benefit}
}{
\text{money cost}+\text{time cost}+\text{risk}
}}
]
The formula is conceptual, but it prevents the common error of equating expense or technological sophistication with effectiveness. The wearable RCT evidence gives good reason for that caution. citeturn4search27
Strategies across income levels
| Resource position | Rational priority for the marginal health dollar | What money is chiefly buying | What to postpone |
|---|---|---|---|
| Severely constrained income | Food security, safe shelter, necessary medicines/care, tobacco cessation if relevant, transportation to care, free/low-cost movement | Removal of basic biological and access constraints | Luxury fitness, elaborate trackers, speculative longevity products |
| Low-to-moderate disposable income | Stable access to care, basic exercise setup, higher-quality diet, sleep conditions, targeted prevention, small purchases that materially improve adherence | Reliability and continuity | Expensive optimization before basic risks are controlled |
| Middle income | Time-saving health infrastructure, convenient exercise access, rehabilitation/coaching where needed, safer environment, childcare or scheduling improvements | Time and reduced friction | Multiple overlapping subscriptions/devices with no demonstrated behavioral effect |
| High income | Time autonomy, high-quality evidence-based medical coordination, safer environment, skilled coaching/rehabilitation when useful, targeted treatment based on genuine risk | Expertise, environment and optionality | Prestige spending with weak outcome evidence; endless biomarker optimization |
| Very high income / marginal private returns low | Maintain fundamentals; direct additional resources toward family/community/public-health environments where constraints are larger | Social capability and external benefits | Assuming another personal longevity dollar must outperform alternative uses |
This table is a decision framework, not an empirical assertion that every person in an income category has the same needs. The underlying evidence supports heterogeneity: cash has shown large effects where constraints are severe, whereas substantial lottery wealth had very small adult physical-health effects in an affluent universal-care environment. citeturn15search19turn20view2
For policymakers: build conditions that let money become health
The policy version of the argument is more powerful than the luxury-consumer version.
Treat health as both human capital and intrinsic capability. The World Bank explicitly places health inside human capital, but policy evaluation should not stop at productivity gains. citeturn17search1 Capability theory adds the ethical reason: health expands people’s substantive freedom whether or not every additional healthy year raises measured GDP. citeturn18search28
Target binding constraints rather than assuming cash alone is always sufficient. Unconditional transfers have strong advantages — flexibility, dignity and the ability of households to identify their own constraints — and Kenyan randomized evidence demonstrates substantial welfare gains. citeturn15search19 Yet the Swedish lottery findings show that once many public inputs are already supplied, unrestricted additional wealth need not generate large adult mortality gains. citeturn20view1 The appropriate cash-versus-service mix is therefore institutional and context dependent.
Invest in environments, not only individual motivation. Moving to Opportunity provides randomized evidence that changing neighborhood exposure can improve adult physical-health outcomes. citeturn15search3turn15search28 Policies affecting housing quality, neighborhood safety, mobility and access to healthy routines can therefore be genuine health-capital policies even when they are not labeled “health care.”
Make high-value preventive interventions easy to use. Smoking cessation combines inexpensive treatment with unusually strong evidence; structured diabetes prevention and evidence-based cardiovascular-risk control likewise represent cases where clinical knowledge can be translated into durable health gains. citeturn16search3turn14search0turn14search20 Policy should be evaluated not merely by whether a service exists but whether eligible people can realistically access and adhere to it.
Measure healthy capability rather than medical expenditure. Oregon’s Medicaid experiment is a warning against treating utilization as the endpoint: coverage increased care use and produced important financial and mental-health benefits without statistically significant short-run improvements in several physical biomarkers. citeturn14search2 More medical spending is not definitionally more health capital.
Incorporate distribution into cost-effectiveness. A dollar’s health return can vary dramatically with deprivation. The contrast among the Chetty income gradient, Kenyan cash experiments and Swedish lottery findings makes it unreasonable to assume a constant conversion coefficient between dollars and healthy life. citeturn15search0turn15search19turn20view0 Evaluations should therefore report not just average cost per health outcome but who receives the gain and what constraint was relaxed.
Final assessment
The strongest version of the original proposition is not:
The body is the ultimate capital, so money should be spent on maximizing it.
That statement is terminologically unconventional, philosophically contentious and empirically too linear.
A more rigorous conclusion is:
Health is foundational embodied capital and, more deeply, a foundational capability. Financial capital is a flexible means of protecting and expanding it. The conversion works best when money removes a binding constraint or purchases a proven intervention; it exhibits substantial heterogeneity and likely diminishing marginal returns.
The philosophical frameworks then line up in a revealing way. Stoicism says the body is worth stewarding but cannot be the ultimate good. citeturn17search3 Utilitarianism says bodily investment must compete against alternative uses by its consequences for well-being. citeturn18search25 The capability approach says income is a means and genuine human functioning and freedom are closer to the end. citeturn18search16turn18search28 Human-capital theory explains why current expenditures can produce future productive capacity. citeturn19search0 Grossman’s health economics formalizes health as a durable stock generating healthy time. citeturn18search3
The empirical literature adds the decisive qualification: wealth is potential energy, not biological energy. Huge income–longevity gradients exist, but randomized wealth shocks do not reproduce those gradients automatically. citeturn15search0turn20view0 Money has its highest bodily return when converted through the right mechanism — tobacco cessation for a smoker, diabetes prevention for a high-risk person, cardiovascular treatment for someone who needs it, an environment that permits healthier living, adequate food and care under poverty, or enough time and reduced friction to sustain sleep and exercise. citeturn16search3turn14search0turn14search20turn15search28turn15search19
The practical rule for both individuals and governments is therefore:
[
\boxed{
\textbf{Do not maximize health spending. Maximize durable health capability per scarce dollar and hour.}
}
]
And beyond the economic metaphor, the deepest qualification is this: a strong body enlarges the space in which a life can be lived, but the value of that life cannot be reduced to the value of the body that carries it.